Literature DB >> 2627143

[Deletion of the long arm of chromosome 18, primary hypothyroidism, Biermer's anemia and IgM hypogammaglobulinemia].

B Henrot1, J Ninane, C Mercenier, C Vermylen, C Verellen, G Cornu, P Malvaux.   

Abstract

We report the case of an adolescent girl who presents with the 18q-syndrome, primary hypothyroidism, pernicious anemia and IgM hypogammaglobulinemia. Her karyotype was performed during infancy because of malformations and showed deletion of the long arm of chromosome 18. The patient had been treated with levothyroxine (Elthyrone) since age 13 when primary hypothyroidism was documented. A close hematological follow-up was then undertaken due to the presence of anti-parietal cell antibodies. A megaloblastic anemia of sudden offset led to the diagnosis of pernicious anemia by age 16, which was confirmed by a positive Shilling's test. Recently, the patient was found to have antimicrosome antibodies and moderate IgM hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2627143

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  3 in total

1.  Case report of de novo dup(18p)/del(18q) and r(18) mosaicism.

Authors:  Enkhtuvshin Gereltzul; Yoshiyuki Baba; Naoto Suda; Momotoshi Shiga; Maristela Sayuri Inoue; Michiko Tsuji; Insik Shin; Yukio Hirata; Kimie Ohyama; Keiji Moriyama
Journal:  J Hum Genet       Date:  2008-08-05       Impact factor: 3.172

2.  The 18q- syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2.

Authors:  G A Silverman; S S Schneider; H F Massa; A Flint; M Lalande; J C Leonard; J Overhauser; G van den Engh; B J Trask
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

3.  18q deletion in a cystic fibrosis infant, increased morbidity and challenge for correct treatment choices: a case report.

Authors:  Elide Spinelli; Silviana Timpano; Annalisa Fogazzi; Silvia Dester; Susanna Milianti; Rita Padoan
Journal:  Ital J Pediatr       Date:  2011-05-17       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.